TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

10681	Companies
228016	Keywords
156518	Articles
120878	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 3 months ago

Transgene franchit des étapes clés en 2024, avec la preuve de principe clinique de son vaccin individualisé contre le cancer ? Perspectives prometteuses pour 2025
Transgene publie ses résultats annuels 2024 et fait le point sur son activité, notamment la preuve de principe clinique de son vaccin individualisé contre le cancer. Perspectives prometteuses pour 2025

Résultats Annuels Perspectives Cancer Transgene Vaccin Thérapeutique
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 3 months ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof
BRIEF

published on 01/21/2025 at 17:50, 1 year 5 months ago

Transgene se prépare pour le Biomed Forum des investisseurs

Investisseurs BIOMED Forum Immunothérapie Transgene Vecteurs Viraux
BRIEF

published on 01/21/2025 at 17:50, 1 year 5 months ago

Transgene Prepares for Biomed Investor Forum

Investors BIOMED Forum Immunotherapy Transgene Viral Vectors
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 5 months ago

Transgene participera à la conférence investisseurs Biomed Forum
Transgene participera à la conférence investisseurs Biomed Forum le 4 février 2025. Présentation de ses immunothérapies contre le cancer reposant sur des vecteurs viraux

BIOMED Forum Immunothérapie Cancer Transgene Vecteurs Viraux
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 5 months ago

Transgene to Participate in the Biomed Forum Investor Conference
Transgene's management team to participate in the Biomed Forum Investor Conference in Paris on February 4, 2025

Investor Conference Paris BIOMED Forum Transgene February 4
BRIEF

published on 11/05/2024 at 07:35, 1 year 8 months ago

Transgene et ProBioGen unissent leurs forces pour les vaccins anti-cancer personnalisés

Biotechnologie Cancer Transgene ProBioGen Vaccins Personnalisés
BRIEF

published on 11/05/2024 at 07:35, 1 year 8 months ago

Transgene and ProBioGen join forces for personalized cancer vaccines

Biotechnology Cancer Transgene ProBioGen Personalized Vaccines
PRESS RELEASE

published on 11/05/2024 at 07:30, 1 year 8 months ago

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés
Transgene et ProBioGen collaborent pour développer les vaccins thérapeutiques individualisés, annoncent un accord de licence pour la lignée cellulaire AGE1.CR.pIX®

Transgene Vaccins ProBioGen Thérapeutiques Lignée Cellulaire
PRESS RELEASE

published on 10/14/2024 at 07:30, 1 year 8 months ago

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Accesswire

Published on 07/03/2026 at 23:00, 1 day 15 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 1 day 15 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 1 day 16 hours ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 18 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/05/2026 at 13:45, 36 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 36 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 20 hours 46 minutes ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 3 hours ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 5 hours ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

Les Echos

Published on 07/03/2026 at 21:49, 1 day 16 hours ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day 16 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 19 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 1 day 19 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 1 day 19 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE